10.57647/jnsc.2026.1602.08

Cyclodextrin-Linked Corn Starch Nanostructured Microgels as pH-Responsive Nanocarriers for Doxorubicin Delivery in Hepatocellular Carcinoma

  1. Department of General Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China
  2. Department of Oncology, Shijiazhuang First Hospital, Shijiazhuang, Hebei, 050000, China
  3. Department of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China

Received: 09-12-2025

Revised: 04-01-2026

Accepted: 03-02-2026

Published in Issue 30-04-2026

How to Cite

Wang, S., Pan, T., Zhang, J., Guo, H., & Yang, W. (2026). Cyclodextrin-Linked Corn Starch Nanostructured Microgels as pH-Responsive Nanocarriers for Doxorubicin Delivery in Hepatocellular Carcinoma. Journal of Nanostructure in Chemistry, 16(2 (April 2026). https://doi.org/10.57647/jnsc.2026.1602.08

PDF views: 10

Abstract

Hepatocellular carcinoma chemotherapy remains constrained by off-target toxicity and multidrug resistance, underscoring the need for biobased nanostructured carriers capable of tumor microenvironment-responsive drug delivery. Here, we report cyclodextrin-linked corn starch nanostructured microgels prepared by inverse water-in-oil emulsion crosslinking with epichlorohydrin as a sustainable platform for doxorubicin delivery. Systematic variation of the β-cyclodextrin content generated colloidally stable microgels with hydrodynamic diameters in the 215–410 nm range, narrow polydispersity indices (~0.22–0.31) and increasingly negative zeta potentials down to −21.5 mV. Nitrogen sorption, FTIR, XRD and thermal analyses confirmed the formation of mesoporous polymer networks, with the lead formulation (CS-CD-3) exhibiting a BET surface area of 12.45 m²/g and an average pore diameter of 9.8 nm. Doxorubicin loading into these microgels afforded high drug payloads with an encapsulation efficiency of 78.4% for CS-CD-3. In vitro release studies demonstrated pronounced pH-dependent behavior, with only ~24% cumulative release at physiological pH 7.4 versus ~72% at pH 5.0 after 24 h, consistent with the intrinsic pH-dependent ionization of doxorubicin and the associated pH-modulated DOX–β-cyclodextrin host–guest interactions within the microgel network. Kinetic fitting of the pH 5.0 release data (Higuchi and Korsmeyer–Peppas models) indicated diffusion through a hydrated matrix with an additional polymer-relaxation contribution under acidic in vitro conditions (n ≈ 0.62). Blank microgels preserved >90% cell viability in both HepG2 and L02 cells, whereas doxorubicin-loaded CS-CD-3 microgels decreased the IC50 in HepG2 cells from 2.15 ± 0.18 to 0.85 ± 0.12 μg/mL and increased the IC50 in L02 cells from 4.50 ± 0.35 to 8.20 ± 0.65 μg/mL, improving the selectivity index from 2.09 to 9.64. Confocal imaging confirmed efficient endocytic uptake, endo-lysosomal release and enhanced apoptotic nuclear damage. These results highlight nanostructured cyclodextrin–starch microgels as a promising bio-derived nanoplatform for safer, more selective hepatocellular carcinoma chemotherapy.

Keywords

  • Bio-based Polysaccharide Nanocarriers,
  • β-cyclodextrin Crosslinked Microgels,
  • Mesoporous Polymer Networks,
  • Selective Cancer Chemotherapy Tumor,
  • Microenvironment-responsive Release

References

  1. Reference
  2. Chan, S.L., Sun, H.-C., Xu, Y., Zeng, H., El-Serag, H.B., Lee, J.M., Schwartz, M.E., Finn, R.S., Seong, J., Wang, X.W., Paradis, V., Abou-Alfa, G.K., Rimassa, L., Kao, J.-H., Zhang, B.-H., Llovet, J.M., Bruix, J., Yip, T.C.-F., Wong, V.W.-S., Wong,G.L.-H., Chan, L.L., Liu, M.-Q., Gao, Q., Shen, F., Kelley, R.K., Cheng, A.-L., Kurosaki, M., Toyoda, H., Chen, W.-X., Murakami, T., Liang, P., Zucman-Rossi, J., Minami, Y., Miyayama, S., Wang, K., Man, K., Hasegawa, K., Li, Q., Tsuchiya, K., Xu, L., Chew, V., Chow, P., Hoshida, Y., Lujambio, A., Ng, I.O.-L., Sakamoto, M., Park, Y.N., Yau, T., Kudo, M., Fan, J., Zhou, J. The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet 406, 731–778 (2025).
  3. Pulumati, A., Pulumati, A., Dwarakanath, B.S., Verma, A., Papineni, R.V.L. Technological advancements in cancer diagnostics: improvements and limitations. Cancer Rep. 6, e1764 (2023).
  4. Anand, U., Dey, A., Chandel, A.K.S., Sanyal, R., Mishra, A., Pandey, D.K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., Dhanjal, J.K., Dewanjee, S., Vallamkondu, J., Pérez de la Lastra, J.M. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 10, 1367–1401 (2022).
  5. Sinha, S.J., Kumar, B., Prasad, C.P., Chauhan, S.S., Kumar, M. Emerging research and future directions on doxorubicin: a snapshot. Asian Pac. J. Cancer Prev. 26, 5–15 (2025).
  6. Sritharan, S., Sivalingam, N. A comprehensive review on time-tested anticancer drug doxorubicin. Life Sci. 278, 119527 (2021).
  7. Lim, J.X., Yong, Y.K., Dewi, F.R.P., Chan, S.Y., Lim, V. Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches. Drug Deliv. Transl. Res. 15, 3835–3863 (2025).
  8. Kumbhar, D.C.J.R. Stimuli-responsive (smart) drug delivery systems: an in-depth review. (2025).
  9. Scheffold, F. Pathways and challenges towards a complete characterization of microgels. Nat. Commun. 11, 4315 (2020).
  10. Aparna, T.N., Kumar, R., Ali, S.R., Patel, D.J., Julekha, K., Begum, T., Bala, J., Kumar, P. Silica nanoparticles: a promising vehicle for anti-cancer drugs delivery. AAPS PharmSciTech 26, 33 (2025).
  11. Baumann, F., Paul, T., Wassersleben, S., Regenthal, R., Enke, D., Aigner, A. Characterization of drug release from mesoporous SiO₂-based membranes with variable pore structure and geometry. Pharmaceutics 14, 1184 (2022).
  12. Benalaya, I., Alves, G., Lopes, J., Silva, L.R. A review of natural polysaccharides: sources, characteristics, properties, food, and pharmaceutical applications. Int. J. Mol. Sci. 25, 1322 (2024).
  13. Jabeen, N., Atif, M. Polysaccharides based biopolymers for biomedical applications: a review. Polym. Adv. Technol. 35, e6203 (2024).
  14. Behrooznia, Z., Nourmohammadi, J. Polysaccharide-based materials as an eco-friendly alternative in biomedical, environmental, and food packaging. Giant 19, 100301 (2024).
  15. Yu, J.-K., Moon, Y.-S. Corn starch: quality and quantity improvement for industrial uses. Plants 11, 92 (2022).
  16. Amaraweera, S.M., Gunathilake, C., Gunawardene, O.H.P., Fernando, N.M.L., Wanninayaka, D.B., Dassanayake, R.S., Rajapaksha, S.M., Manamperi, A., Fernando, C.A.N., Kulatunga, A.K., Manipura, A. Development of starch-based materials using current modification techniques and their applications: a review. Molecules 26, 6880 (2021).
  17. Li, Y., Zhang, F., Wang, B., Liu, J., Wang, Y., Shi, Z., Du, L., Wang, K., Zhang, W., Wang, Z., Dou, L. Synergistic epichlorohydrin-crosslinked carboxymethyl xylan for enhanced thermal stability and filtration control in water-based drilling fluids. Gels 11, 666 (2025).
  18. Chen, L., Zhang, D., Wei, L.-F., Zhu, W.-J., Yan, X.-Q., Zhou, R., Din, Z., Ding, W.-P., Ma, T.-Z., Cai, J. Structural and mechanistic insights into starch microgel/anthocyanin complex assembly and controlled release performance. Int. J. Biol. Macromol. 213, 718–727 (2022).
  19. Xu, W., Li, X., Wang, L., Li, S., Chu, S., Wang, J., Li, Y., Hou, J., Luo, Q., Liu, J. Design of cyclodextrin-based functional systems for biomedical applications. Front. Chem. 9 (2021).
  20. Zhao, R., Tang, B., Xu, Z., Fang, G. β-Cyclodextrin-based polyelectrolyte complexes for drug delivery. Coord. Chem. Rev. 534, 216581 (2025).
  21. Nanda, D., Behera, D., Pattnaik, S.S., Behera, A.K. Advances in natural polymer-based hydrogels: synthesis, applications, and future directions in biomedical and environmental fields. Discov. Polym. 2, 6 (2025).
  22. Nanta, P., Kasemwong, K., Grisdanurak, N. Production and characterization of starch microspheres using supercritical carbon dioxide assisted spray drying. Int. J. Biol. Macromol. 305, 141197 (2025).
  23. Vagena, I.-A., Malapani, C., Gatou, M.-A., Lagopati, N., Pavlatou, E.A. Enhancement of EPR effect for passive tumor targeting: current status and future perspectives. Appl. Sci. 15, 3189 (2025).
  24. Hosonuma, M., Yoshimura, K. Association between pH regulation of the tumor microenvironment and immunological state. Front. Oncol. 13, 1175563 (2023).
  25. Obadi, M., Qi, Y., Xu, B. High-amylose maize starch: structure, properties, modifications and industrial applications. Carbohydr. Polym. 299, 120185 (2023).
  26. Madrid, F., Rubio-Bellido, M., Morillo, E. Extraction of nonylphenol, pyrene and phenanthrene from sewage sludge and composted biosolids by cyclodextrins and rhamnolipids. Sci. Total Environ. 715, 136986 (2020).
  27. Krishnan, K.K., Thomas, A.M., Sindhu, K.S., Anilkumar, G. Recent advances and perspectives in the manganese-catalysed epoxidation reactions. Tetrahedron 72, 1–16 (2016).
  28. Mehryab, F., Ebrahimi, M., Baharvand, H., Haeri, A., Shekari, F. Extracellular vesicle-based formulation of doxorubicin: drug loading optimization, characterization, and cytotoxicity evaluation in tumor spheroids. Pharm. Dev. Technol. 29, 727–737 (2024).
  29. Lv, Y., He, H., Qi, J., Lu, Y., Zhao, W., Dong, X., Wu, W. Visual validation of the measurement of entrapment efficiency of drug nanocarriers. Int. J. Pharm. 547, 395–403 (2018).
  30. Oh, Y.J., Hong, J. Application of the MTT-based colorimetric method for evaluating bacterial growth using different solvent systems. LWT 153, 112565 (2022).
  31. Jonkman, J., Brown, C.M., Wright, G.D., Anderson, K.I., North,A.J. Tutorial: guidance for quantitative confocal microscopy. Nat. Protoc. 15, 1585–1611 (2020).
  32. Wu, S., Hatahet, T., Bona, B.L., Lodigiani, G., Zhang, M., Bombelli, F.B., Al-Jamal, W.T. Incorporating Span 80 surfactant into lipid nanocapsules improves their biocompatibility and cellular uptake in B16F10 melanoma cells. Int. J. Pharm. 672, 125358 (2025).
  33. Salleh, K.M., Zakaria, S., Sajab, M.S., Gan, S., Chia, C.H., Jaafar, S.N.S., Amran, U.A. Chemically crosslinked hydrogel and its driving force towards superabsorbent behaviour. Int. J. Biol. Macromol. 118, 1422–1430 (2018).
  34. Nicu, R., Lisa, G., Darie-Nita, R.N., Avadanei, M.I., Bargan, A., Rusu, D., Ciolacu, D.E. Tailoring the structure and physico-chemical features of cellulose-based hydrogels using multi-epoxy crosslinking agents. Gels 10, 523 (2024).
  35. Zeng, Y., Zhao, M., Zeng, H., Jiang, Q., Ming, F., Xi, K., Wang, Z., Liang, H. Recent progress in advanced catalysts for electrocatalytic hydrogenation of organics in aqueous conditions. eScience 3, 100156 (2023).
  36. Vogel, R., Pal, A.K., Jambhrunkar, S., Patel, P., Thakur, S.S., Reátegui, E., Parekh, H.S., Saá, P., Stassinopoulos, A., Broom, M.F. High-resolution single particle zeta potential characterisation of biological nanoparticles using tunable resistive pulse sensing. Sci. Rep. 7, 17479 (2017).
  37. Greenfield, N.J. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 1, 2876–2890 (2006).
  38. Park, S.-H. Cd content dependence of in-plane optical polarization in anisotropically strained c-plane CdZnO/ZnO quantum wells. Physica B 596, 412393 (2020).
  39. Lim, S.H., Wong, T.W., Tay, W.X. Overcoming colloidal nanoparticle aggregation in biological milieu for cancer therapeutic delivery: perspectives of materials and particle design. Adv. Colloid Interface Sci. 325, 103094 (2024).
  40. Kypr, J., Kejnovská, I., Renčiuk, D., Vorlíčková, M. Circular dichroism and conformational polymorphism of DNA. Nucleic Acids Res. 37, 1713–1725 (2009).
  41. Wang, L., Chen, S., Li, C., Gu, Z., Kong, H., Ban, X., Li, Z. Enhancement of β-cyclodextrin production using a glycogen debranching enzyme from Saccharolobus solfataricus STB09. J. Agric. Food Chem. 72, 6491–6499 (2024).
  42. Yang, X., Yokokura, S., Nagahama, T., Yamaguchi, M., Shimada, T. Molecular dynamics simulation of poly(ether ether ketone) polymer to analyze intermolecular ordering by low wavenumber Raman spectroscopy and X-ray diffraction. Polymers 14, 5406 (2022).
  43. Li, Z., Pu, L., Hou, D., Yan, J., Zeng, Q., Chen, Y. A macrocycle-assisted platform approach to protein cross-linking via chemically inactive residues. Nano Lett. 25, 3489–3496 (2025).
  44. Krishnaswamy, S. IR spectrum and characteristic absorption bands. (n.d.). Zhou, J., Zhang, Z., Li, X., Yin, J., Zhou, J., Wu, M. A novel fingerprint recognition strategy driven by convolutional autoencoders and attention mechanisms. in: Proc. 4th Int. Conf. Artificial Intelligence, Robotics, and Communication, 893–900 (2024).
  45. Glover, J.D., Sudderick, Z.R., Shih, B.B.-J., Batho-Samblas, C., Charlton, L., Krause, A.L., Anderson, C., Riddell, J., Balic, A., Li, J., Klika, V., Woolley, T.E., Gaffney, E.A., Corsinotti, A.,
  46. Anderson, R.A., Johnston, L.J., Brown, S.J., Wang, S., Chen, Y., Crichton, M.L., Headon, D.J. The developmental basis of fingerprint pattern formation and variation. Cell 186, 940–956.e20 (2023).
  47. Wang, H., Zhao, P., Ma, R., Jia, J., Fu, Q. Drug–drug co-amorphous systems: an emerging formulation strategy for poorly water-soluble drugs. Drug Discov. Today 29, 103883 (2024).
  48. Datta, K., van Laar, S.C.W., Taddei, M., Hidalgo, J., Kodalle, T., Aalbers, G.J.W., Lai, B., Li, R., Tamura, N., Frencken, J.T.W., Quiroz Monnens, S.V., Westbrook, R.J.E., Graham, D.J., Sutter-Fella, C.M., Correa-Baena, J.-P., Ginger, D.S., Wienk, M.M., Janssen, R.A.J. Local halide heterogeneity drives surface wrinkling in mixed-halide wide-bandgap perovskites. Nat. Commun. 16, 1967 (2025).
  49. Rivas-Barbosa, R., Camerin, F., Vialetto, J., Ramakrishna, S.N., Isa, L., Zaccarelli, E. Comparing the structure of microgels at liquid–liquid and solid–liquid interfaces. Langmuir 41, 16674–16684 (2025).
  50. Gordillo-Galeano, A., Mora-Huertas, C.E. Hydrodynamic diameter and zeta potential of nanostructured lipid carriers: emphasizing some parameters for correct measurements. Colloids Surf. A 620, 126610 (2021).
  51. Chen, K., Zhang, T., Chen, X., He, Y., Liang, X. Model construction of micro-pores in shale: a case study of Silurian Longmaxi Formation shale in Dianqianbei area, SW China. Pet. Explor. Dev. 45, 412–421 (2018).
  52. Chai, L., Wang, P., Liu, X., Sun, Y., Li, X., Pan, J. Accurately control the micropore/mesopore ratio to construct a new hierarchical porous carbon with ultrahigh capacitance and rate performance. J. Power Sources 532, 231324 (2022).
  53. Xu, B., Li, S., Shi, R., Liu, H. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct. Target. Ther. 8, 435 (2023).
  54. He, Y., Zheng, Y., Liu, C., Zhang, H., Shen, J. Citric acid cross-linked β-cyclodextrins: a review of preparation and environmental/biomedical application. Carbohydr. Polym. 323, 121438 (2024).
  55. Sichina, W.J. Characterization of polymers using TGA. (n.d.). Wu, Z., Chu, C., Jin, Y., Yang, L., Qian, B., Wang, Y., Wang, Y., Wu, J., Jia, Y., Zhang, W., You, Z. Dynamic cross-linked topological network reconciles the longstanding contradictory properties of polymers. Sci. Adv. 11, eadt0825 (2025).
  56. Mal, A., Prabhuraj, R.S., Malhotra, R., Valvi, S.K., Ingle, A., Srivastava, R., De, A., Bandyopadhyaya, R. pH-responsive sustained delivery of doxorubicin using aminated and PEGylated mesoporous silica nanoparticles leads to enhanced antitumor efficacy in pre-clinical orthotopic breast cancer model. J. Drug Deliv. Sci. Technol. 77, 103800 (2022).
  57. Tsuchitani, T., Kato, M., Tomaru, A., Aoki, Y., Sugiyama, Y. Trends of in vitro pharmacological potency and in vivo pharmacokinetics parameters of modern drugs: can the therapeutic/subtherapeutic dose be estimated from in vitro Ki and pharmacokinetic parameters? Clin. Transl. Sci. 17, e70034 (2024).
  58. Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., Kontek, R. Doxorubicin—an agent with multiple mechanisms of anticancer activity. Cells 12, 659 (2023).
  59. Zhang, M., Zhang, G., Meng, X., Wang, X., Xie, J., Wang, S., Wang, B., Wang, J., Liu, S., Huang, Q., Yang, X., Li, J., Wang, H. Reduction of the oxidative damage to H₂O₂-induced HepG2 cells via the Nrf2 signalling pathway by plant flavonoids quercetin and hyperoside. Food Sci. Hum. Wellness 13, 1864–1876 (2024).